hims glp-1 results & Hers Data Shows Personalized Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care Welcome to the family, new

The underreported symptoms are leads that came from patients themselves, unprompted, and clinicians could potentially pay attention to them. Although the study is not representative of the broader populationReddit users are generally younger, more likely male and based in the U.S.the symptoms reported collectively match known side effects of semaglutide and tirzepatide

The most likely patient would be one who needs a 1% or less reduction in A1C to meet glycemic goals and does not wish to start insulin

Questions remain regarding muscle loss, nutritional adequacy, long-term neurological effects, and what happens when treatment is stopped

From a practical standpoint, patients are unable to get employer benefits for medication, which now almost upwards of 50% of our country can potentially qualify for

Key Differences at a Glance Dosing Wegovy pill: Daily tablet on an empty stomach Injectable GLP-1s: Weekly self-injection Weight Loss Wegovy pill: ~1317% at 64 weeks Injectable GLP-1s: ~15%+ at 68 weeks Blood Sugar Impact Wegovy pill: Strong effect on insulin resistance with modest A1c reduction Injectables: Slightly greater A1c reductions overall Side Effects Wegovy pill: Similar GI effects (nausea, diarrhea)

Zhou Q, Guan W, Qiao H, Cheng Y, Li Z, Zhai X, Zhou Y